Mybacs: Improving Health with Microbiome
Aiming to revolutionize intestinal healthcare, Mybacs focuses on the development of innovative and highly-dosed synbiotic supplements tailored to individual needs.
Mybacs, a Swiss biotechnology company, specializes in human microbiome to help people with intestinal and digestive problems and improve overall health. Their synbiotic product, Dailybacs, contains selected bacterial cultures, prebiotics from plant extracts, valuable minerals, and vitamins. And this unique formulation can support our bodies beyond digestion.
The idea started when founders Carl-Philipp von Polheim and Sebastian Wahl were trying to develop a treatment for traveler’s diarrhea. But the endless research into microbial bacteria led to the creation of Mybacs in 2018. Because they believe that better health starts with better ingredients and that microbiome is the mirror of our health.
The Mybacs team is constantly working with scientists and doctors from all over the world to keep updated with new research. This is their way to ensure they give their customers only the best product.
Find out more:
For more information, you can contact them here.
Nestlé and ETH Zurich Start Research Program to Reduce Carbon Footprint of Agricultural Raw Materials
Nestlé and ETH Zurich establish a new...
Swiss startup Mootral starts the...
The EPFL campus has provided new...
As its contribution to food...